What is the role of regulatory agencies in cancer drug approval?
Regulatory agencies such as the FDA (U.S. Food and Drug Administration) and the EMA (European Medicines Agency) play a crucial role in the approval of new cancer drugs and therapies. They evaluate the data from preclinical and clinical studies to ensure that the new treatment is safe and effective for patients. These agencies also monitor post-marketing data to ensure ongoing safety and efficacy.
